Abstract #1151

Chronic hepatic encephalopathy in early developing brain, neurometabolic changes differ depending on the age of disease onset, in vivo longitudinal 1H MRS study

Veronika Rackayova¹, Olivier Braissant², Valerie McLin³, and Cristina Cudalbu¹

¹CIBM, EPFL, Lausanne, Switzerland, ²Service of Biomedicine, Neurometabolic Unit, Lausanne University Hospital, Lausanne, Switzerland, ³Swiss Center for Liver Disease in Children, University Hospitals Geneva, Geneva, Switzerland

Chronic hepatic encephalopathy (CHE) due to chronic liver disease (CLD) causes irreversible cognitive deficits in children. We aimed to study possible differences in neurometabolic changes in rat model of CLD&CHE depending on the age of the disease onset (post-natal day 15 vs 21), using in-vivo ¹H-MRS. We showed differences in Gln, tCho, Lac, Asc, GSH and neurotransmitter concentrations between p15 and p21 pups during the evolution of the disease. These differences suggest that age of disease onset and its coincidence with neurodevelopmental processes play an important role and may result in different vulnerability to the disease depending on the age.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.